Atlas Trials

Do HMG CoA Reductase Inhibitors Affect Abeta Levels?

Clinical trial NCT00303277 · COMPLETED

Trial details

NCT number
NCT00303277
Sponsor
Seattle Institute for Biomedical and Clinical Research
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Alzheimer's DiseaseAging
Start date
2002-08-01
Primary completion
2005-04-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.